Organization
Smilow Cancer Hospital
4 abstracts
Abstract
Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer.Org: Dana-Farber Cancer Institute, Yale School of Medicine, University of Pittsburgh Medical Center (UPMC), Yale Cancer Center, Harvard Medical School,
Abstract
Impact of HER2 low status on genomic signatures in triple negative breast cancer (TNBC).Org: Yale New Haven Hospital, New Haven, CT, Upstate University Hospital, Syracuse, NY, SUNY Upstate University Hospital,
Abstract
Real world outcomes of patients with small cell lung cancer (SCLC) presenting with brain metastasis at diagnosis in a single institution health system.Org: Yale New Haven Hospital, Yale University, Department of Therapeutic Radiology, Yale School of Medicine, Department of Neurosurgery, Peking Union Medical College Hospital, Beijing, China,
Abstract
The impact of oncology hospitalist utilization on resident education.Org: Yale University, Yale School of Medicine, Smilow Cancer Hospital, Yale New Haven Hospital, Yale Cancer Center/Smilow Cancer Hospital at Yale New Haven Health,